Rilpivirine long-acting nanosuspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rilpivirine long-acting nanosuspension, covering 2025-02-03 to 2025-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Effect of Different Particle Sizes on the Single-dose Pharmacokinetics of Rilpivirine After Intramuscular Injection of a Long-acting Nanosuspension in Healthy Participants [Phase 1]